Diabetes Mellitus (DM) and Disorders of Blood Sugar Metabolism

Hand pointer Thorne glucose test is most commonly used to monitor blood glucose levels. Most glucose monitoring devices (glucometer) use a drop of blood obtained by piercing the tip of a finger with a small lancet. The lancet holds a thin needle that can be inserted into the fingers or can be placed in the spring device to penetrate the skin easily and quickly. Most people believe that stinging pain causes minimal discomfort. Next, place a drop of blood on the reagent strip. The strip contains chemicals that change according to the level of glucose. The meter reads the change in the test strip and reports the result to the digital display. Depending on the device, blood samples can be taken from other places such as the palm, forearm, upper arm, thigh, or calf. Household glucose meter is less than card deck

The Continuous Blood Glucose Monitoring (CGM) system uses a small glucose sensor located under the skin. The sensor measures the blood sugar level every few minutes. There are two kinds of CGMs with different uses.

Professional CGM collects continuous blood glucose information over a period of time (72 hours to 14 days). Health care providers use this information to decide treatment recommendations. Professional CGM does not provide data for diabetic patients

In the past, it was necessary to manually divide the glucose test and frequently calibrate the CGM. In addition, since these results are not sufficiently accurate, people should always check their CGM readings before confirming their CGM reading (eg before meals or before correcting hyperglycemia) before calculating insulin dosage You must do the guidelines. However, recent advances in technology have improved CGM. Professional CGM can be worn for up to 14 days without calibration. Another personal CGM can be used to instruct insulin administration without having to check glucose by hand. Finally, there are systems where the CGM device communicates with the insulin pump to stop delivery of insulin (threshold pause) when the blood glucose level falls, or administer insulin daily (mixed closed loop system).

Most people with diabetes need to record blood glucose levels and report advice on adjusting insulin dosage or oral hypoglycemic drugs to the physician or nurse. Many people can learn to adjust insulin dosage as needed. Some people with mild or early type 2 diabetes that are successfully controlled with one or two medications can occasionally monitor blood glucose levels with their own fingertips in rare circumstances

Diabetes (DM): DM is a disease in which the body can not regulate blood glucose levels. Diabetic dogs show a healthy appetite, but their weight decreases as food is not being used effectively. Symptoms of diabetes are excessive urination and thirst, increased appetite, weight loss. Diabetes can be controlled by diet and insulin administration. Progressive retinal atrophy (PRA): This is a family of eye diseases with progressive deterioration of the retina. In the early stages of the disease, the affected dog becomes night blind; as the disease progresses, they become blind during the day. As long as the surrounding environment is the same, many affected dogs adapt well for limited vision or loss of vision.

Diabetes (DM) is a group of metabolic disorders in which blood glucose (hyperglycemia) is caused by absolute or relative lack of insulin or both. There are many classifications of this disease entity based on pathological processes leading to hyperglycemia. In type II DM, hyperglycemia is caused by a series of major insulin resistance with relative insulin deficiency, an insulin secretion disorder with predominantly insulin resistance (Fauci et al., 2008). Normally, it occurs in elderly people (> 30 years old), but the diagnosis of young people is increasing (Tidy, 2009). "Most of the diabetes symptoms occur later in the stages, many people with diabetes have no symptoms even if the initial blood glucose level rises" (National Objectives for Health, 2005)

Type 2 diabetes (formerly non-insulin dependent diabetes) is a metabolic disorder characterized by insulin resistance and hyperglycemia (hyperglycemia) which is relatively insulin-deficient. This is in contrast to type 1 diabetes, where insulin is not present at all due to destruction of pancreatic islet cells. Three research reports published in May 2013 to the American Journal of Medicine noted that cannabis can play an important role in controlling human blood glucose levels. In this survey, 4,657 people including active and original marijuana users were examined, the current cannabis user decreased the fasting insulin level by 16%, the HOMA-IR by 17%, the insulin resistance and the beta cell function Has been measured. GW Pharmaceuticals also developed type 2 diabetes drug GW 42004.